Skip to menu Skip to content Skip to footer

2014

Journal Article

Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration

Escobar, Leslie, Andresen, Max, Downey, Patricio, Gai, Maria Nella, Regueira, Tomas, Borquez, Tamara, Lipman, Jeffrey and Roberts, Jason A. (2014). Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration. International Journal of Antimicrobial Agents, 44 (2), 163-167. doi: 10.1016/j.ijantimicag.2014.03.009

Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration

2014

Journal Article

Preface

Zoltan, Horvoelgyi, Eva, Kiss and Etelka, Tombacz (2014). Preface. Periodica Polytechnica-Chemical Engineering, 58, 1-1. doi: 10.1007/978-981-10-5336-8

Preface

2014

Journal Article

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

Sime, Fekade Bruck, Roberts, Michael S., Warner, Morgyn S., Hahn, Uwe, Robertson, Thomas A., Yeend, Sue, Phay, Andy, Lehman, Sheila, Lipman, Jeffrey, Peake, Sandra L. and Roberts, Jason A. (2014). Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy. Antimicrobial Agents and Chemotherapy, 58 (6), 3533-3537. doi: 10.1128/AAC.02340-14

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

2014

Journal Article

Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration

Varghese, Julie M., Jarrett, Paul, Boots, Robert J., Kirkpatrick, Carl M. J., Lipman, Jeffrey and Roberts, Jason A. (2014). Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents, 43 (4), 343-348. doi: 10.1016/j.ijantimicag.2014.01.009

Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration

2014

Journal Article

Individualization of piperacillin dosing for critically ill patients: Dosing software to optimize antimicrobial therapy

Felton, T. W., Roberts, J. A., Lodise, T. P., Van Guilder, M., Boselli, E., Neely, M. N. and Hope, W. W. (2014). Individualization of piperacillin dosing for critically ill patients: Dosing software to optimize antimicrobial therapy. Antimicrobial Agents and Chemotherapy, 58 (7), 4094-4102. doi: 10.1128/AAC.02664-14

Individualization of piperacillin dosing for critically ill patients: Dosing software to optimize antimicrobial therapy

2013

Journal Article

Can optimal drug dosing during ECMO improve outcomes?

Shekar, Kiran, Fraser, John F. and Roberts, Jason A. (2013). Can optimal drug dosing during ECMO improve outcomes?. Intensive Care Medicine, 39 (12), 2237-2237. doi: 10.1007/s00134-013-3080-z

Can optimal drug dosing during ECMO improve outcomes?

2013

Journal Article

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

Udy, Andrew A., Roberts, Jason A. and Lipman, Jeffrey (2013). Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Medicine, 39 (12), 2070-2082. doi: 10.1007/s00134-013-3088-4

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

2013

Journal Article

Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients

Adnan, Syamhanin, Paterson, David L., Lipman, Jeffrey and Roberts, Jason A. (2013). Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients. International Journal of Antimicrobial Agents, 42 (5), 384-389. doi: 10.1016/j.ijantimicag.2013.07.012

Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients

2013

Journal Article

What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review

Parker, Suzanne, Lipman, Jeffrey, Koulenti, Despoina, Dimopoulos, George and Roberts, Jason A. (2013). What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review. International Journal of Antimicrobial Agents, 42 (4), 289-293. doi: 10.1016/j.ijantimicag.2013.05.018

What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review

2013

Journal Article

Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?

Putt, M. T., Udy, A. A., Jarrett, P., Martin, J., Hennig, S., Salmon, N., Lipman, J. and Roberts, J. A. (2013). Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?. Anaesthesia and Intensive Care, 41 (5), 602-609. doi: 10.1177/0310057x1304100505

Phenytoin loading doses in adult critical care patients: does current practice achieve adequate drug levels?

2013

Journal Article

A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study

Dulhunty, Joel M., Roberts, Jason A., Davis, Joshua S., Webb, Steven A. R., Bellomo, Rinaldo, Gomersall, Charles, Shirwadkar, Charudatt, Eastwood, Glenn M., Myburgh, John, Paterson, David L., Starr, Therese, Udy, Andrew A., Paul, Sanjoy K. and Lipman, Jeffrey (2013). A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical Care and Resuscitation, 15 (3), 179-185.

A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study

2013

Journal Article

Electron microscope detection of an endogenous infection of retrovirus-like particles in L20B cells

Roberts, Jason A., Thorley, Bruce R., Bruggink, Leesa D. and Marshall, John A. (2013). Electron microscope detection of an endogenous infection of retrovirus-like particles in L20B cells. Journal of Electron Microscopy, 62 (4), 485-486. doi: 10.1093/jmicro/dfs133

Electron microscope detection of an endogenous infection of retrovirus-like particles in L20B cells

2013

Journal Article

Reply to Soman et al

Dulhunty, Joel M., Roberts, Jason A., Davis, Joshua S., Webb, Steven A. R., Bellomo, Rinaldo, Gomersall, Charles, Shirwadkar, Charudatt, Eastwood, Glenn M., Myburgh, John, Paterson, David L. and Lipman, Jeffrey (2013). Reply to Soman et al. Clinical Infectious Diseases, 57 (2), 323-324. doi: 10.1093/cid/cit201

Reply to Soman et al

2013

Journal Article

Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains

Adnan, Syamhanin, Li, Janice Xuanhui, Wallis, Steven C., Rudd, Michael, Jarrett, Paul, Paterson, David L., Lipman, Jeffrey, Udy, Andrew A. and Roberts, Jason A. (2013). Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains. International Journal of Antimicrobial Agents, 42 (1), 90-93. doi: 10.1016/j.ijantimicag.2013.02.023

Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains

2013

Journal Article

ANNUAL REPORT OF THE AUSTRALIAN NATIONAL ENTEROVIRUS REFERENCE LABORATORY 2012

Roberts, Jason, Hobday, Linda, Ibrahim, Aishah, Aitken, Thomas and Thorley, Bruce (2013). ANNUAL REPORT OF THE AUSTRALIAN NATIONAL ENTEROVIRUS REFERENCE LABORATORY 2012. Communicable Diseases Intelligence, 37 (2), E97-E104.

ANNUAL REPORT OF THE AUSTRALIAN NATIONAL ENTEROVIRUS REFERENCE LABORATORY 2012

2013

Journal Article

Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

Udy, Andrew A., Covajes, Cecilia, Taccone, Fabio Silvio, Jacobs, Frederique, Vincent, Jean-Louis, Lipman, Jeffrey and Roberts, Jason A. (2013). Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?. International Journal of Antimicrobial Agents, 41 (6), 564-568. doi: 10.1016/j.ijantimicag.2013.01.018

Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

2013

Journal Article

Annual report of the Australian National Enterovirus Reference Laboratory 2010-2011

Roberts, Jason, Hobday, Linda, Ibrahim, Aishah, Aitken, Thomas and Thorley, Bruce (2013). Annual report of the Australian National Enterovirus Reference Laboratory 2010-2011. Communicable Diseases Intelligence Quarterly Report, 37 (2), E105-E114.

Annual report of the Australian National Enterovirus Reference Laboratory 2010-2011

2013

Journal Article

Annual report of the Australian National Enterovirus Reference Laboratory 2012

Roberts, Jason, Hobday, Linda, Ibrahim, Aishah, Aitken, Thomas and Thorley, Bruce (2013). Annual report of the Australian National Enterovirus Reference Laboratory 2012. Communicable Diseases Intelligence Quarterly Report, 37 (2), E97-E104.

Annual report of the Australian National Enterovirus Reference Laboratory 2012

2013

Journal Article

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

Carlier, Mieke, Carrette, Sofie, Roberts, Jason A., Stove, Veronique, Verstraete, Alain, Hoste, Eric, Depuydt, Pieter, Decruyenaere, Johan, Lipman, Jeffrey, Wallis, Steven C. and De Waele, Jan J. (2013). Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?. Critical Care, 17 (3) R84, R84.1-R84.9. doi: 10.1186/cc12705

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

2013

Journal Article

Digoxin prescription in the critically ill: an unpredictably loaded problem?

Mrara, B., Roberts, J. A. and Gowardman, J. (2013). Digoxin prescription in the critically ill: an unpredictably loaded problem?. Anaesthesia and Intensive Care, 41 (3), 434-436.

Digoxin prescription in the critically ill: an unpredictably loaded problem?